Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Open and closed-loop control systems01:17

Open and closed-loop control systems

1.8K
Control systems are foundational elements in automation and engineering. They are broadly categorized into open-loop and closed-loop systems. These classifications hinge on the presence or absence of feedback mechanisms, significantly influencing the system's performance, complexity, and application.
An open-loop control system operates without feedback from the output. It consists of two primary elements: the controller and the controlled process. The controller receives an input signal...
1.8K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Long-term Depression01:05

Long-term Depression

33.4K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
33.4K
Long-term Depression01:03

Long-term Depression

3.4K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
3.4K
Freezing Point Depression and Boiling Point Elevation03:12

Freezing Point Depression and Boiling Point Elevation

40.5K
Boiling Point Elevation
The boiling point of a liquid is the temperature at which its vapor pressure is equal to ambient atmospheric pressure. Since the vapor pressure of a solution is lowered due to the presence of nonvolatile solutes, it stands to reason that the solution’s boiling point will subsequently be increased. Vapor pressure increases with temperature, and so a solution will require a higher temperature than will pure solvent to achieve any given vapor pressure, including one...
40.5K
Depressants01:28

Depressants

474
Depressant drugs, including alcohol and sedative-hypnotics, diminish central nervous system activity by enhancing the action of gamma-aminobutyric acid (GABA), a neurotransmitter that reduces brain activity and promotes relaxation. These substances can have various therapeutic uses but also pose significant risks, especially when misused or combined.
Alcohol is a common depressant that can induce a sense of relaxation and reduced inhibition at low doses. Contrary to its occasional...
474

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reward pursuit during a translational reward task correlates with anhedonia reductions following rTMS in patients with major depressive disorder.

Translational psychiatry·2026
Same author

Prefrontal cortical pathways mediating cognitive control enhancement from internal capsule stimulation.

bioRxiv : the preprint server for biology·2026
Same author

Unilateral striatal deep brain stimulation improves cognitive control.

The Journal of neuroscience : the official journal of the Society for Neuroscience·2026
Same author

Sex-biased computations underlying differential set shift performance in mice.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology·2026
Same author

Comparison of neuropsychological side effects between contemporary radiofrequency ablative neurosurgery for psychiatric disorders and conventional neurosurgical procedures: systematic review and meta-analysis.

Journal of neurology, neurosurgery, and psychiatry·2026
Same author

The Use of Vagus Nerve Stimulation (VNS) in the Management of Patients with Difficult-to-Treat Major Depressive Disorder (MDD): An Expert Consensus Statement.

Neuropsychiatric disease and treatment·2026

Related Experiment Video

Updated: Feb 12, 2026

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment
05:19

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment

Published on: July 7, 2023

3.5K

Closing the Loop on Deep Brain Stimulation for Treatment-Resistant Depression.

Alik S Widge1, Donald A Malone2, Darin D Dougherty1

  • 1Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States.

Frontiers in Neuroscience
|April 6, 2018
PubMed
Summary

Deep brain stimulation (DBS) for treatment-resistant depression shows promise but requires better targeting. Future closed-loop systems using brain-computer interfaces (BCI) may improve outcomes by personalizing therapy.

Keywords:
brain circuitsbrain-computer interfacesdeep brain stimulationdepressionelectrophysiologyneuro-imagingneuromodulation

More Related Videos

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
04:29

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Published on: January 7, 2019

29.6K
MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
08:20

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Published on: August 11, 2015

14.7K

Related Experiment Videos

Last Updated: Feb 12, 2026

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment
05:19

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment

Published on: July 7, 2023

3.5K
Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
04:29

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Published on: January 7, 2019

29.6K
MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
08:20

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Published on: August 11, 2015

14.7K

Area of Science:

  • Neuroscience and Psychiatry
  • Neuromodulation and Brain-Computer Interfaces (BCI)

Background:

  • Major depressive episodes represent a significant cause of psychiatric disability, often proving resistant to conventional treatments.
  • Deep brain stimulation (DBS), successful in movement disorders, was explored for treatment-resistant depression.
  • Early open-label DBS studies showed dramatic results, but subsequent controlled trials yielded inconsistent outcomes.

Purpose of the Study:

  • To review the results of DBS for treatment-resistant depression within a technology-lifecycle framework.
  • To analyze the reasons for inconsistent trial outcomes, particularly the lack of physiologic targeting.
  • To predict the future trajectory of DBS technology for psychiatric applications.

Main Methods:

  • Review of open-label and blinded clinical trials investigating DBS for treatment-resistant depression.
  • Analysis of study results through the lens of a technology-lifecycle model.
  • Integration of recent mechanistic insights and brain-computer interface (BCI) advancements.

Main Results:

  • Initial enthusiasm for DBS in depression was tempered by inconsistent results in controlled trials.
  • Inconsistent outcomes are attributed to inadequate targeting of physiologic responses.
  • The technology lifecycle framework suggests DBS for depression is moving from disillusionment towards enlightenment.

Conclusions:

  • Next-generation DBS, informed by mechanistic insights and BCI, can improve therapeutic targeting.
  • Development of closed-loop systems for semi-autonomous stimulation adjustment based on patient phenotype is crucial.
  • Advanced DBS approaches hold significant potential for enhancing psychiatric care for treatment-resistant depression.